Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PFIZER vs NATCO PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PFIZER NATCO PHARMA PFIZER/
NATCO PHARMA
 
P/E (TTM) x 38.2 13.4 285.5% View Chart
P/BV x 6.0 3.5 170.5% View Chart
Dividend Yield % 1.7 0.6 289.8%  

Financials

 PFIZER   NATCO PHARMA
EQUITY SHARE DATA
    PFIZER
Mar-23
NATCO PHARMA
Mar-23
PFIZER/
NATCO PHARMA
5-Yr Chart
Click to enlarge
High Rs4,662847 550.6%   
Low Rs3,407502 678.7%   
Sales per share (Unadj.) Rs530.0148.4 357.2%  
Earnings per share (Unadj.) Rs136.439.2 347.9%  
Cash flow per share (Unadj.) Rs159.448.2 330.9%  
Dividends per share (Unadj.) Rs70.005.50 1,272.7%  
Avg Dividend yield %1.70.8 212.7%  
Book value per share (Unadj.) Rs701.0267.1 262.5%  
Shares outstanding (eoy) m45.75182.47 25.1%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x7.64.5 167.5%   
Avg P/E ratio x29.617.2 172.0%  
P/CF ratio (eoy) x25.314.0 180.8%  
Price / Book Value ratio x5.82.5 227.9%  
Dividend payout %51.314.0 365.8%   
Avg Mkt Cap Rs m184,576123,049 150.0%   
No. of employees `000NANA-   
Total wages/salary Rs m3,3174,867 68.1%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m24,24827,071 89.6%  
Other income Rs m1,0111,285 78.6%   
Total revenues Rs m25,25828,356 89.1%   
Gross profit Rs m8,4209,117 92.3%  
Depreciation Rs m1,0551,638 64.4%   
Interest Rs m135145 93.0%   
Profit before tax Rs m8,2408,619 95.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,0011,466 136.5%   
Profit after tax Rs m6,2397,153 87.2%  
Gross profit margin %34.733.7 103.1%  
Effective tax rate %24.317.0 142.8%   
Net profit margin %25.726.4 97.4%  
BALANCE SHEET DATA
Current assets Rs m24,93330,003 83.1%   
Current liabilities Rs m6,5746,831 96.2%   
Net working cap to sales %75.785.6 88.5%  
Current ratio x3.84.4 86.4%  
Inventory Days Days9363 147.2%  
Debtors Days Days2115 2.0%  
Net fixed assets Rs m13,78026,571 51.9%   
Share capital Rs m458365 125.3%   
"Free" reserves Rs m31,61648,373 65.4%   
Net worth Rs m32,07348,738 65.8%   
Long term debt Rs m00-   
Total assets Rs m39,03156,574 69.0%  
Interest coverage x62.160.4 102.8%   
Debt to equity ratio x00-  
Sales to assets ratio x0.60.5 129.8%   
Return on assets %16.312.9 126.6%  
Return on equity %19.514.7 132.5%  
Return on capital %26.118.0 145.2%  
Exports to sales %2.80-   
Imports to sales %010.2 0.3%   
Exports (fob) Rs m688NA-   
Imports (cif) Rs m82,772 0.3%   
Fx inflow Rs m68817,256 4.0%   
Fx outflow Rs m82,772 0.3%   
Net fx Rs m67914,484 4.7%   
CASH FLOW
From Operations Rs m3,5578,491 41.9%  
From Investments Rs m-361-4,771 7.6%  
From Financial Activity Rs m-3,458-3,630 95.3%  
Net Cashflow Rs m-262208 -125.8%  

Share Holding

Indian Promoters % 0.0 49.7 -  
Foreign collaborators % 63.9 0.0 -  
Indian inst/Mut Fund % 18.2 25.0 72.8%  
FIIs % 3.0 13.7 22.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 36.1 50.3 71.7%  
Shareholders   112,456 207,571 54.2%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PFIZER With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Pfizer vs Natco Pharma

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Pfizer vs Natco Pharma Share Price Performance

Period Pfizer Natco Pharma S&P BSE HEALTHCARE
1-Day -4.83% -1.81% 1.18%
1-Month -8.27% -2.89% -0.75%
1-Year 21.74% 73.33% 61.82%
3-Year CAGR -2.08% 5.07% 18.16%
5-Year CAGR 4.94% 11.03% 19.79%

* Compound Annual Growth Rate

Here are more details on the Pfizer share price and the Natco Pharma share price.

Moving on to shareholding structures...

The promoters of Pfizer hold a 63.9% stake in the company. In case of Natco Pharma the stake stands at 49.7%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Pfizer and the shareholding pattern of Natco Pharma.

Finally, a word on dividends...

In the most recent financial year, Pfizer paid a dividend of Rs 70.0 per share. This amounted to a Dividend Payout ratio of 51.3%.

Natco Pharma paid Rs 5.5, and its dividend payout ratio stood at 14.0%.

You may visit here to review the dividend history of Pfizer, and the dividend history of Natco Pharma.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.